Forte Biosciences Inc [FBRX] stock is trading at $33.39, up 2.14%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The FBRX shares have gain 39.82% over the last week, with a monthly amount glided 43.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Forte Biosciences Inc [NASDAQ: FBRX] stock has seen the most recent analyst activity on November 25, 2025, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $65. Previously, Guggenheim started tracking the stock with Buy rating on August 18, 2025, and set its price target to $75. On January 21, 2025, TD Cowen initiated with a Buy rating. Ladenburg Thalmann upgraded its rating to a Buy but stick to its price target of $2.75 on April 08, 2024. Chardan Capital Markets upgraded its rating to a Buy and reduced its price target to $3.50 on September 20, 2021. Truist downgraded its rating to Hold for this stock on September 03, 2021, but kept the price target unchanged to $4. In a note dated September 03, 2021, Ladenburg Thalmann downgraded an Neutral rating on this stock.
Forte Biosciences Inc [FBRX] stock has fluctuated between $4.90 and $34.19 over the past year. Currently, Wall Street analysts expect the stock to reach $65 within the next 12 months. Forte Biosciences Inc [NASDAQ: FBRX] shares were valued at $33.39 at the most recent close of the market. An investor can expect a potential return of 94.67% based on the average FBRX price forecast.
Analyzing the FBRX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.76 and Total Capital is -0.64.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Forte Biosciences Inc’s Current Ratio is 7.34. As well, the Quick Ratio is 7.34, while the Cash Ratio is 7.19.
Transactions by insiders
Recent insider trading involved Riley Antony A, CHIEF FINANCIAL OFFICER, that happened on Dec 30 ’25 when 9680.0 shares were purchased.
